Sun Pharmaceutical Industries Limited has informed the Exchange that Record date for the purpose of Dividend is 07-Jul-2025.
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sun Pharma's board met on 22 May 2025 and approved audited standalone and consolidated financial results for Q4 and FY25 with an unmodified auditor opinion. Standalone revenue from operations rose to Rs. 23,003 crore (vs Rs. 20,275 crore in FY24), while net profit jumped to Rs. 4,283 crore from Rs. 2,858 crore, with EPS of Rs. 17.8 vs Rs. 11.9. The board recommended a final dividend of Rs. 5.50 per share, taking the total FY25 dividend to Rs. 16 per share (including the Rs. 10.50 interim declared in January 2025). The record date for the final dividend is fixed as 07 July 2025, with payment on or before 08 August 2025, subject to AGM approval. The 33rd AGM is scheduled for 31 July 2025 via video conferencing. Additionally, Ms. Vidhi Shanghvi was appointed as Whole-time Director for five years, while Mr. Sudhir Valia retired and did not seek reappointment.
Strong earnings growth (~50% rise in standalone net profit) and a healthy total dividend of Rs. 16 per share signal robust shareholder returns, though dividend yield at current market price remains under 1%. The appointment of a Shanghvi family member as Whole-time Director indicates continuity in leadership, while the dividend record date gives clarity to investors on eligibility.